Organoids as Oracles for Precision Medicine in Rectal Cancer.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31951587.
- Also identified by DOI 10.1016/j.stem.2019.12.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two recent papers in Cell Stem Cell and Nature Medicine (Yao et al. [2019] and Ganesh et al. [2019]) demonstrate the successful use of rectal cancer patient-derived organoids to predict patient responses to neoadjuvant chemoradiation therapy, paving the way toward a new paradigm for precision medicine.
Medical subject headings
- Organoids
- Rectal Neoplasms